Regents of the University of California’s Arvinas ARVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-72,616
Closed -$4.89M 37
2022
Q1
$4.89M Sell
72,616
-18,960
-21% -$1.29M 0.73% 10
2021
Q4
$7.52M Buy
91,576
+14,274
+18% +$1.16M 1.05% 9
2021
Q3
$6.35M Buy
+77,302
New +$6.83M 0.75% 11
2020
Q4
Sell
-14,333
Closed -$338K 29
2020
Q3
$338K Buy
+14,333
New +$415K 0.05% 25
2019
Q4
Sell
-20,833
Closed -$449K 30
2019
Q3
$449K Hold
20,833
0.86% 22
2019
Q2
$458K Buy
+20,833
New +$438K 1.29% 21

Other funds holding ARVN

Regents of the University of California's ARVN Position: Q2 2022 in Review

Regents of the University of California sold out of Arvinas (ARVN) in Q2 2022, closing a stake of 72,616 shares — an estimated $4.89M sold.

Regents of the University of California first reported a position in ARVN in Q2 2019 and held it in 6 quarters. The position peaked at $7.52M in Q4 2021. 171 funds tracked by Wall St. Rank hold ARVN as of Q2 2022.

  • Regents of the University of California reported no remaining Arvinas position as of Q2 2022 after selling out during the quarter.
  • Regents of the University of California sold 72,616 Arvinas shares in Q2 2022, an estimated $4.89M.
  • Regents of the University of California first reported a position in Arvinas in Q2 2019 and held it in 6 quarters.
  • Regents of the University of California's Arvinas position peaked at $7.52M in Q4 2021.
  • 171 funds tracked by Wall St. Rank held Arvinas as of Q2 2022.

Based on Regents of the University of California's 13F filing for Q2 2022, filed 5 Aug 2022.